Cero Therapeutics Holdings, Inc.
CEROW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4 in total; no superinvestor holds it.
Other share classesCERO
13F holders, Q3 2025
Institutional positions in Cero Therapeutics Holdings, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q2 2025
- Shares held
- 2.84M
- +96.9K (+3.5%) vs. Q2 2025
- Total value
- $38.1K
- −$25.4K (−40.0%) vs. Q2 2025
- New holders
- 2
- 1 more added
- Sold out
- 1
- 2 more reduced
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CEROW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 1 | $11 |
| Q4 2025 | 1 | $22 |
| Q3 2025 | 22 | $38.1K |
| Q2 2025 | 23 | $74.5K |
| Q1 2025 | 26 | $45.7K |
| Q4 2024 | 27 | $28.6K |
| Q3 2024 | 31 | $28.0K |
| Q2 2024 | 35 | $110.3K |
| Q1 2024 | 38 | $425.3K |
| Q4 2023 | 41 | $135.1K |
| Q3 2023 | 44 | $423.7K |
| Q2 2023 | 44 | $351.0K |
| Q1 2023 | 47 | $234.9K |
| Q4 2022 | 50 | $264.8K |
| Q3 2022 | 44 | $503.0K |
| Q2 2022 | 42 | $550.0K |
| Q1 2022 | 36 | $1.02M |
| Q4 2021 | 31 | $1.35M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Cero Therapeutics Holdings, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Street Group Inc. | 461,653 | $6.14K | 0.00% | +461,653 | New |
| Toronto Dominion Bank | 381,018 | $5.33K | 0.00% | −300−0.1% | Reduced |
| MMCAP International Inc. SPC | 375,000 | $4.99K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 295,913 | $4.26K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 249,999 | $3.60K | 0.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 224,930 | $2.99K | 0.00% | 00.0% | Unchanged |
| Q Global Advisors, LLC | 170,785 | $2.00K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 122,013 | $1.62K | 0.00% | 00.0% | Unchanged |
| Highland Capital Management Fund Advisors, L.P. | 108,741 | $1.45K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 98,468 | $1.31K | 0.00% | +98,468 | New |
| Picton Mahoney Asset Management | 75,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 74,998 | $997 | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 50,000 | $665 | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 33,796 | $449 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 27,500 | $366 | 0.00% | −22,500−45.0% | Reduced |
| Whitebox Advisors LLC | 23,250 | $309 | 0.00% | 00.0% | Unchanged |
| DuPont Capital Management Corp | 12,500 | $166 | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 12,500 | $166 | 0.00% | 00.0% | Unchanged |
| Silver Rock Financial LP | 12,224 | $163 | 0.00% | 00.0% | Unchanged |
| Fortress Financial Solutions, LLC | 10,000 | $133 | 0.00% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 2,500 | $33 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 21,104 | $0 | 0.00% | +630+3.1% | Added |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −441,048−100.0% | Sold out |
| Clear Street Derivatives LLC | – | – | – | – | Not filed |
| Clear Street LLC | – | – | – | – | Not filed |